Duplication of the A17L locus of vaccinia virus provides an alternate route to rifampin resistance

Journal of Virology

Volumn 88, Issue 19, 2014, Pages 11576-11585

  Erlandson, Karl J ^a   Cotter, Catherine A ^a   Charity, James C ^a   Martens, Craig ^b   Fischer, Elizabeth R ^b   Ricklefs, Stacy M ^b   Porcella, Stephen F ^b   Moss, Bernard ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MEMBRANE PROTEIN; PROTEIN A17; RIFAMPICIN; UNCLASSIFIED DRUG;

ANTIVIRAL RESISTANCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; GENE DUPLICATION; GENE INSERTION; GENE LOCUS; IMMATURE VIRUS; NONHUMAN; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; PHENOTYPE; PROTEIN BINDING; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; VACCINIA VIRUS; VIRUS CULTURE; VIRUS ENVELOPE; VIRUS GENOME; VIRUS MUTANT; WILD TYPE; AMINO ACID SEQUENCE; ANIMAL; CELL LINE; CHLOROCEBUS AETHIOPS; DRUG EFFECT; EPITHELIUM CELL; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENETICS; MOLECULAR GENETICS; SEQUENCE ALIGNMENT; VIRION; VIROLOGY; VIRUS ASSEMBLY; VIRUS GENE;

AMINO ACID SEQUENCE; ANIMALS; CELL LINE; CERCOPITHECUS AETHIOPS; DRUG RESISTANCE, VIRAL; EPITHELIAL CELLS; GENE DUPLICATION; GENE EXPRESSION; GENES, VIRAL; GENETIC LOCI; MOLECULAR SEQUENCE DATA; MUTAGENESIS, INSERTIONAL; OPEN READING FRAMES; RIFAMPIN; SEQUENCE ALIGNMENT; VACCINIA VIRUS; VIRION; VIRUS ASSEMBLY;

EID: 84906990863     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00618-14     Document Type: Article

References (40)

1. Moss B. 2013. Poxviridae, p 2129-2159. In Knipe DM, Howley PM (ed), Fields virology, sixth ed, vol 2. Lippincott Williams & Wilkins, Philadelphia, PA.
2. Heuser J. 2005. Deep-etch EM reveals that the early poxvirus envelope is a single membrane bilayer stabilized by a geodetic "honeycomb" surface coat. J. Cell Biol. 169:269-283. http://dx.doi.org/10.1083/jcb.200412169.
3. Szajner P, Weisberg AS, Lebowitz J, Heuser J, Moss B. 2005. External scaffold of spherical immature poxvirus particles is made of protein trimers, forming a honeycomb lattice. J. Cell Biol. 170:971-981. http://dx.doi.org/10.1083/jcb.200504026.
4. Hyun JK, Accurso C, Hijnen M, Schult P, Pettikiriarachchi A, Mitra AK, Coulibaly F. 2011. Membrane remodeling by the double-barrel scaffolding protein of poxvirus. PLoS Pathog. 7(9):e1002239. http://dx.doi.org/10.1371/journal.ppat.1002239.
5. Bisht H, Weisberg AS, Szajner P, Moss B. 2009. Assembly and disassembly of the capsid-like external scaffold of immature virions during vaccinia virus morphogenesis. J. Virol. 83:9140-9150. http://dx.doi.org/10.1128/JVI.00875-09.
6. Zhang Y, Moss B. 1992. Immature viral envelope formation is interrupted at the same stage by lac operator-mediated repression of the vaccinia virus D13L gene and by the drug rifampicin. Virology 187:643-653. http://dx.doi.org/10.1016/0042-6822(92)90467-4.
7. Rodri´guez D, Esteban M, Rodri´guez JR. 1995. Vaccinia virus A17L gene product is essential for an early step in virion morphogenesis. J. Virol. 69:4640-4648.
8. Wolffe EJ, Moore DM, Peters PJ, Moss B. 1996. Vaccinia virus A17L open reading frame encodes an essential component of nascent viral membranes that is required to initiate morphogenesis. J. Virol. 70:2797-2808.
9. Rodriguez D, Rodriguez JR, Esteban M. 1993. The vaccinia virus 14-kilodalton fusion protein forms a stable complex with the processed protein encoded by the vaccinia virus A17L gene. J. Virol. 67:3435-3440.
10. Betakova T, Wolffe EJ, Moss B. 1999. Regulation of vaccinia virus morphogenesis: phosphorylation of the A14L and A17L membrane proteins and C-terminal truncation of the A17L protein are dependent on the F10L protein kinase. J. Virol. 73:3534-3543.
11. Derrien M, Punjabi A, Khanna R, Grubisha O, Traktman P. 1999. Tyrosine phosphorylation of A17 during vaccinia virus infection: Involvement of the H1 phosphatase and the F10 kinase. J. Virol. 73:7287-7296.
12. Ansarah-Sobrinho C, Moss B. 2004. Role of the I7 protein in proteolytic processing of vaccinia virus membrane and core components. J. Virol. 78:6335-6343. http://dx.doi.org/10.1128/JVI.78.12.6335-6343.2004.
13. Matson J, Chou W, Ngo T, Gershon PD. 2014. Static and dynamic protein phosphorylation in the vaccinia virion. Virology 452:310-323. http://dx.doi.org/10.1016/j.virol.2014.01.012.
14. Unger B, Mercer J, Boyle KA, Traktman P. 2013. Biogenesis of the vaccinia virus membrane: genetic and ultrastructural analysis of the contributions of the A14 and A17 proteins. J. Virol. 87:1083-1097. http://dx.doi.org/10.1128/JVI.02529-12.
15. Krijnse-Locker J, Schleich S, Rodriguez D, Goud B, Snijder EJ, Griffiths G. 1996. The role of a 21-kDa viral membrane protein in the assembly of vaccinia virus from the intermediate compartment. J. Biol. Chem. 271: 14950-14958. http://dx.doi.org/10.1074/jbc.271.25.14950.
16. Betakova T, Wolffe EJ, Moss B. 1999. Membrane topology of the vaccinia virus A17L envelope protein. Virology 261:347-356. http://dx.doi.org/10.1006/viro.1999.9870.
17. Maruri-Avidal L, Weisberg AS, Moss B. 2013. Direct formation of vaccinia viral membranes from the endoplasmic reticulum in the absence of the newly characterized L2-interacting A30.5 protein. J. Virol. 87:12313- 12326. http://dx.doi.org/10.1128/JVI.02137-13.
18. Moss B, Rosenblum EN, Katz E, Grimley PM. 1969. Rifampicin: a specific inhibitor of vaccinia virus assembly. Nature 224:1280-1284. http://dx.doi.org/10.1038/2241280a0.
19. Grimley PM, Rosenblum EN, Mims SJ, Moss B. 1970. Interruption by rifampin of an early stage in vaccinia virus morphogenesis: accumulation of membranes which are precursors of virus envelopes. J. Virol. 6:519-533.
20. Nagayama A, Pogo BG, Dales S. 1970. Biogenesis of vaccinia: separation of early stages from maturation by means of rifampicin. Virology 40: 1039-1051. http://dx.doi.org/10.1016/0042-6822(70)90150-9.
21. Sodeik B, Griffiths G, Ericsson M, Moss B, Doms RW. 1994. Assembly of vaccinia virus: effects of rifampin on the intracellular distribution of viral protein p65. J. Virol. 68:1103-1114.
22. Grimley PM, Moss B. 1971. Similar effect of rifampin and other rifamycin derivatives on vaccinia virus morphogenesis. J. Virol. 8:225-231.
23. Tartaglia J, Piccini A, Paoletti E. 1986. Vaccinia virus rifampicin resistance locus specifies a late 63,000 Da gene product. Virology 150:45-54. http://dx.doi.org/10.1016/0042-6822(86)90264-3.
24. Baldick CJ, Moss B. 1987. Resistance of vaccinia virus to rifampicin conferred by a single nucleotide substitution near the predicted NH2 terminus of a gene encoding an Mr 62,000 polypeptide. Virology 156:138- 145. http://dx.doi.org/10.1016/0042-6822(87)90444-2.
25. McNulty-Kowalczyk A, Paoletti E. 1993. Mutations in ORF D13L and other genetic loci alter the rifampicin phenotype of vaccinia virus. Virology 194:638-646. http://dx.doi.org/10.1006/viro.1993.1303.
26. Charity JC, Katz E, Moss B. 2007. Amino acid substitutions at multiple sites within the vaccinia virus D13 scaffold protein confer resistance to rifampicin. Virology 359:227-232. http://dx.doi.org/10.1016/j.virol.2006.09.031.
27. Slabaugh MB, Roseman NA, Mathews CK. 1989. Amplification of the ribonucleotide reductase small subunit gene: analysis of novel joints and the mechanism of gene duplication in vaccinia virus. Nucleic Acids Res. 17:7073-7088. http://dx.doi.org/10.1093/nar/17.17.7073.
28. Elde NC, Child SJ, Eickbush MT, Kitzman JO, Rogers KS, Shendure J, Geballe AP, Malik HS. 2012. Poxviruses deploy genomic accordions to adapt rapidly against host antiviral defenses. Cell 150:831-841. http://dx.doi.org/10.1016/j.cell.2012.05.049.
29. Brennan G, Kitzman JO, Rothenburg S, Shendure J, Geballe AP. 2014. Adaptive gene amplification as an intermediate step in the expansion of virus host range. PLoS Pathog. 10(3):e1004002. http://dx.doi.org/10.1371/journal.ppat.1004002.
30. Fuerst TR, Niles EG, Studier FW, Moss B. 1986. Eukaryotic transientexpression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase. Proc. Natl. Acad. Sci. U. S. A. 83: 8122-8126. http://dx.doi.org/10.1073/pnas.83.21.8122.
31. Blasco R, Moss B. 1995. Selection of recombinant vaccinia viruses on the basis of plaque formation. Gene 158:157-162. http://dx.doi.org/10.1016/0378-1119(95)00149-Z.
32. Earl PL, Cooper N, Wyatt LS, Moss B, Carroll MW. 2001. Preparation of cell cultures and vaccinia virus stocks. Curr. Protoc. Mol. Biol. Chapter 16:Unit16.16. http://dx.doi.org/10.1002/0471142727.mb1616s43.
33. Abyzov A, Urban AE, Snyder M, Gerstein M. 2011. CNVnator: an approach to discover, genotype, and characterize typical and atypical CNVs from family and population genome sequencing. Genome Res. 21: 974-984. http://dx.doi.org/10.1101/gr.114876.110.
34. Kim D, Pertea G, Trapnell C, Pimentel H, Kelley R, Salzberg SL. 2013. TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions. Genome Biol. 14:R36. http://dx.doi.org/10.1186/gb-2013-14-4-r36.
35. Simpson DA, Condit RC. 1995. Vaccinia virus gene A18R encodes an essential DNA helicase. J. Virol. 69:6131-6139.
36. Lackner CA, Condit RC. 2000. Vaccinia virus gene A18R DNA helicase is a transcript release factor. J. Biol. Chem. 275:1485-1494. http://dx.doi.org/10.1074/jbc.275.2.1485.
37. Satheshkumar PS, Weisberg AS, Moss B. 2013. Vaccinia virus A19 protein participates in the transformation of spherical immature particles to barrel shaped infectious virions. J. Virol. 87:10700-10709. http://dx.doi.org/10.1128/JVI.01258-13.
38. Satheshkumar PS, Olano LR, Hammer CH, Zhao M, Moss B. 2013. Interactions of the vaccinia virus A19 protein. J. Virol. 87:10710-10720. http://dx.doi.org/10.1128/JVI.01261-13.
39. Betakova T, Moss B. 2000. Disulfide bonds and membrane topology of the vaccinia virus A17L envelope protein. J. Virol. 74:2438-2442. http://dx.doi.org/10.1128/JVI.74.5.2438-2442.2000.
40. Bahar MW, Graham SC, Stuart DI, Grimes JM. 2011. Insights into the evolution of a complex virus from the crystal structure of vaccinia virus D13. Structure 19:1011-1020. http://dx.doi.org/10.1016/j.str.2011.03.023.